Trial Update October 30, 2026

Calcitonin-Related Trial "Dietary Intervention for Migraine Relief" Recruiting

A clinical trial update dated October 30, 2026 lists the study "Dietary Intervention for Migraine Relief" as currently recruiting. The trial, registered as NCT07360405, is listed with a phase designation of not applicable. No results or outcome data have been posted for this trial at this time. The trial's recruiting status indicates that participant enrollment is ongoing as of the date listed. Calcitonin remains an approved compound, and its connection to this particular trial record reflects the trial registry listing rather than any reported finding. No efficacy, safety, or outcome information is included in this update beyond the recruiting status itself. Readers should note that a recruiting status means the trial has not yet reached completion and that no conclusions can be drawn from this update alone. Further updates to this trial record may be issued as the study progresses through recruitment and subsequent phases. For additional context on calcitonin, including its approved regulatory status and general background, readers are encouraged to consult the compound overview.

See the full calcitonin overview

Source: https://clinicaltrials.gov/study/NCT07360405